• Ciliates

    Cilian uses Ciliates of the genus Tetrahymena for the production of therapeutic proteins
    Advantages:
    - High biological safety
    - Secretion of proteins
    - Established fermentation

  • CIPEX-System

    The Ciliate based expression system

    Actual Projects:
    - Monoclonal antibody (biobetter)
    - Flu-Vaccine (recombinant)
    - Human enzymes

  • Service

    Complex proteins of interest to a partner can be developed using the innovative CIPEX-System
    (process development and production up to pilot scale)


  • News

    21.06.2016 “Cilian AG announced that a patent for its MAb production technology have been issued by the European Patent Office.”
    17.12.2015 “CILIAN AG reports positive in vivo results for its seasonal sub-unit flu vaccine, CiFlu®.”